• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: Medtronic Ireland Affera; PERCUTANEOUS CARDIAC ABLATION CATHETER FOR TREATMENT OF ATRIAL FIBRILLATION WITH

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

Medtronic Ireland Affera; PERCUTANEOUS CARDIAC ABLATION CATHETER FOR TREATMENT OF ATRIAL FIBRILLATION WITH Back to Search Results
Model Number AFR-00001
Medical Device Problem Codes Use of Device Problem (1670); No Apparent Adverse Event (3189)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 07/10/2026
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Product event summary: the afr-00001 catheter with lot number 0013331049 was returned and analyzed.No anomalies were identified during external visual inspection of the catheter.The catheter passed the mapping and ablation test with the mapping system (test/lab), no errors were triggered.No performance issues were identified with the catheter.During deflection testing, pushing and pulling steering wings was possible without any anomalies.Leak test was performed to check for any leaks on the irrigation line.The pressure decay was 0.015 pounds per square inch (psi), the catheter passed the test.Occlusion test was performed to check for any blocks in the irrigation line.The pressure drop was 23.912, the catheter passed the test.The catheter passed the shorts test.No errors were triggered.The catheter passed the mapping test.No errors were triggered.No anomalies were identified during the inspection of the sphere segment.All the electrode wires were intact.In conclusion, the reported issues (steam pop, temp rise) were not repr oduced during testing or inspection.The catheter passed the returned product inspection.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
Affera
Common Device Name
PERCUTANEOUS CARDIAC ABLATION CATHETER FOR TREATMENT OF ATRIAL FIBRILLATION WITH
Manufacturer (Section D)
Medtronic Ireland
parkmore business park west
galway
EI 
Manufacturer (Section G)
Medtronic Ireland
parkmore business park west
galway
EI  
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
+353(091)708096
MDR Report Key50143636
Report Number9612164-2026-03932
Device Sequence Number10731408
Product Code QZI
UDI-Device Identifier00199150003709
UDI-Public(01)00199150003709(17)270408(10)0013331049(20)01
Combination Product (Y/N)N
Initial Reporter StateMA
Initial Reporter CountryUS
PMA/510(K) Number
P240013
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 09/23/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberAFR-00001
Device Catalogue NumberAFR-00001
Device Lot Number0013331049
Was Device Available for Evaluation? Yes
Date Returned to Manufacturer07/15/2026
Is the Reporter a Health Professional? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 07/10/2026
Supplement Date Received by Manufacturer08/26/2026
Initial Report FDA Received Date08/05/2026
Supplement Report FDA Received Date09/23/2026
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured03/09/2026
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient Age66 YR
Patient SexMale
Patient Weight194 LB
-
-